Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AMA/Sunbeam

This article was originally published in The Gray Sheet

Executive Summary

American Medical Association will pay Sunbeam $7.9 mil. in damages and $2 mil. for expenses under a settlement agreement announced July 31. The settlement resolves a September 1997 Sunbeam suit designed to hold AMA to the terms of a five-year marketing/educational agreement, which included the use of the AMA symbol on over-the-counter Sunbeam health care products in exchange for inclusion of AMA educational materials with the products ("The Gray Sheet" Sept. 15, 1997, In Brief). AMA put the agreement on hold after concerns were raised that the use of the association's symbol might be perceived as a product endorsement

Latest Headlines
See All
UsernamePublicRestriction

Register

MT010451

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel